Kongressthemen With next generation of complex immuno-oncology candidates, preclinical and translational scientists in the IO space are in need for more predictive tumour models to improve clinical translatability, accelerating speed-to-clinic with confidence.
We are excited to finally reunite this community in December at 11th PREDiCT: Tumour Models London Summit to address the critical next step of narrowing the preclinical gap and progressing efficacious candidates to the clinic.
Speakers: Céline Nicolazzi Group Leader Pharmacology Oncology Sanofi, Antje Margret Wengner Senior Scientist Bayer AG, Aude de Gassart Head of Preclinical Model Development ImCheck Therapeutics